| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |